Skip to main content
Top
Published in: International Ophthalmology 3/2018

01-06-2018 | Original Paper

Clinical and genetic analysis of Indian patients with NDP-related retinopathies

Authors: Dhandayuthapani Sudha, Aparna Ganapathy, Puja Mohan, Ashraf U. Mannan, Shuba Krishna, Srividya Neriyanuri, Meenakshi Swaminathan, Pukhraj Rishi, Subbulakshmi Chidambaram, Jayamuruga Pandian Arunachalam

Published in: International Ophthalmology | Issue 3/2018

Login to get access

Abstract

Purpose

NDP-related retinopathies are a group of X-linked disorders characterized by degenerative and proliferative changes of the neuroretina, occasionally accompanied with varying degrees of mental retardation and sensorineural hearing loss. NDP is the predominant gene associated with NDP-related retinopathies. The purpose of this study was to report the clinical and genetic findings in three unrelated patients diagnosed with NDP-related retinopathies.

Methods

The patients underwent complete ophthalmic examination followed by genetic analyses. NDP gene was screened by direct sequencing approach. Targeted resequencing of several other ocular genes was carried out in patient samples that either indicated NDP gene deletion or tested negative for NDP mutation. Gene quantitation analysis was performed using real-time PCR.

Results

The whole NDP gene was deleted in patient I, while a missense NDP mutation, c.205T>C, was identified in patient II, and both had classical Norrie disease ocular phenotype (with no other systemic defects). Patient III who was diagnosed with familial exudative vitreoretinopathy did not show any mutation in the known candidate genes as well as in other ocular genes tested.

Conclusions

The patient with whole NDP gene deletion did not exhibit any apparent extraocular defects (like mental retardation or sensorineural hearing loss) during his first decade of life, and this is considered to be a notable finding. Our study also provides evidence emphasizing the need for genetic testing which could eliminate ambiguities in clinical diagnosis and detect carrier status, thereby aiding the patient and family members during genetic counseling.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sims KB (1999) NDP-Related Retinopathies. In: Pagon RA, Adam MP, Ardinger HH et al (eds) GeneReviews®. University of Washington, Seattle, pp 1993–2016 Updated 2014 Sims KB (1999) NDP-Related Retinopathies. In: Pagon RA, Adam MP, Ardinger HH et al (eds) GeneReviews®. University of Washington, Seattle, pp 1993–2016 Updated 2014
2.
go back to reference Warburg M (1961) Norrie’s disease: a new hereditary bilateral pseudotumor of the retina. Acta Ophthalmol 39:757–772CrossRef Warburg M (1961) Norrie’s disease: a new hereditary bilateral pseudotumor of the retina. Acta Ophthalmol 39:757–772CrossRef
3.
go back to reference Warburg M (1996) Norrie’s disease. A congenital progressive oculoacoustico-cerebral degeneration. Acta Ophthalmol (Copenh) Suppl 89:1–47 Warburg M (1996) Norrie’s disease. A congenital progressive oculoacoustico-cerebral degeneration. Acta Ophthalmol (Copenh) Suppl 89:1–47
4.
5.
go back to reference Criswick VG, Schepens CL (1968) Familial exudative vitreoretinopathy. Am J Ophthalmol 68:578–594CrossRef Criswick VG, Schepens CL (1968) Familial exudative vitreoretinopathy. Am J Ophthalmol 68:578–594CrossRef
6.
go back to reference Black GC, Perveen R, Bonshek R et al (1999) Coat’s disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet 8:2031–2035CrossRefPubMed Black GC, Perveen R, Bonshek R et al (1999) Coat’s disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet 8:2031–2035CrossRefPubMed
7.
go back to reference Gibson DL, Sheps SB, Uh SH et al (1990) Retinopathy of prematurity-induced blindness: birth weight specific survival and the new epidemic. Pediatrics 86:405–412PubMed Gibson DL, Sheps SB, Uh SH et al (1990) Retinopathy of prematurity-induced blindness: birth weight specific survival and the new epidemic. Pediatrics 86:405–412PubMed
8.
go back to reference Shastry BS (2009) Persistent hyperplastic primary vitreous: congenital malformation of the eye. Clin Exp Ophthalmol 37:884–890CrossRefPubMed Shastry BS (2009) Persistent hyperplastic primary vitreous: congenital malformation of the eye. Clin Exp Ophthalmol 37:884–890CrossRefPubMed
9.
go back to reference Chen ZY, Battinelli EM, Fielder A et al (1993) A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet 5:180–183CrossRefPubMed Chen ZY, Battinelli EM, Fielder A et al (1993) A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet 5:180–183CrossRefPubMed
10.
go back to reference Shastry BS, Pendergast SD, Hartzer MK et al (1997) Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 115:651–655CrossRefPubMed Shastry BS, Pendergast SD, Hartzer MK et al (1997) Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 115:651–655CrossRefPubMed
11.
go back to reference Aponte EP, Pulido JS, Ellison JW et al (2009) A novel NDP mutation in an infant with unilateral persistent fetal vasculature and retinal vasculopathy. Ophthalmic Genet 30(2):99–102CrossRefPubMed Aponte EP, Pulido JS, Ellison JW et al (2009) A novel NDP mutation in an infant with unilateral persistent fetal vasculature and retinal vasculopathy. Ophthalmic Genet 30(2):99–102CrossRefPubMed
12.
go back to reference Berger W, Meindl A, van de Pol TJR et al (1992) Isolation of a candidate gene for Norrie disease by positional cloning. Nature Genet 1:199–203CrossRefPubMed Berger W, Meindl A, van de Pol TJR et al (1992) Isolation of a candidate gene for Norrie disease by positional cloning. Nature Genet 1:199–203CrossRefPubMed
13.
go back to reference Smith SE, Mullen TE, Graham D et al (2012) Norrie disease: extraocular clinical manifestations in 56 patients. Am J Med Genet A 158A:1909–1917CrossRefPubMed Smith SE, Mullen TE, Graham D et al (2012) Norrie disease: extraocular clinical manifestations in 56 patients. Am J Med Genet A 158A:1909–1917CrossRefPubMed
14.
go back to reference Meindl A, Berger W, Meitinger T et al (1992) Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins. Nat Genet 2:139–143CrossRefPubMed Meindl A, Berger W, Meitinger T et al (1992) Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins. Nat Genet 2:139–143CrossRefPubMed
15.
go back to reference Ye X, Wang Y, Cahill H et al (2009) Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 139:285–298CrossRefPubMedPubMedCentral Ye X, Wang Y, Cahill H et al (2009) Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 139:285–298CrossRefPubMedPubMedCentral
16.
go back to reference Hutcheson KA, Paluru PC, Bernstein SL et al (2005) Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol Vis 11:501–508PubMed Hutcheson KA, Paluru PC, Bernstein SL et al (2005) Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol Vis 11:501–508PubMed
17.
go back to reference Dong B, Chen J, Zhang X et al (2013) Two novel PRPF31 premessenger ribonucleic acid processing factor 31 homolog mutations including a complex insertion-deletion identified in Chinese families with retinitis pigmentosa. Mol Vis 19:2426–2435PubMedPubMedCentral Dong B, Chen J, Zhang X et al (2013) Two novel PRPF31 premessenger ribonucleic acid processing factor 31 homolog mutations including a complex insertion-deletion identified in Chinese families with retinitis pigmentosa. Mol Vis 19:2426–2435PubMedPubMedCentral
18.
go back to reference D’haene B, Vandesompele J, Hellemans J (2010) Accurate and objective copy number profiling using real-time quantitative PCR. Methods 50(4):262–270CrossRefPubMed D’haene B, Vandesompele J, Hellemans J (2010) Accurate and objective copy number profiling using real-time quantitative PCR. Methods 50(4):262–270CrossRefPubMed
20.
go back to reference Rodriguez-Revenga L, Madrigal I, Alkhalidi LS et al (2007) Contiguous deletion of the NDP, MAOA, MAOB, and EFHC2 genes in a patient with Norrie disease, severe psychomotor retardation and myoclonic epilepsy. Am J Med Genet A 143A(9):916–920CrossRefPubMed Rodriguez-Revenga L, Madrigal I, Alkhalidi LS et al (2007) Contiguous deletion of the NDP, MAOA, MAOB, and EFHC2 genes in a patient with Norrie disease, severe psychomotor retardation and myoclonic epilepsy. Am J Med Genet A 143A(9):916–920CrossRefPubMed
21.
go back to reference Schuback DE, Chen ZY, Craig IW et al (1995) Mutations in the Norrie Disease Gene. Hum Mutat 5:285–292CrossRefPubMed Schuback DE, Chen ZY, Craig IW et al (1995) Mutations in the Norrie Disease Gene. Hum Mutat 5:285–292CrossRefPubMed
22.
go back to reference Okumura A, Arai E, Kitamura Y et al (2015) Epilepsy phenotypes in siblings with Norrie disease. Brain Dev 37(10):978–982CrossRefPubMed Okumura A, Arai E, Kitamura Y et al (2015) Epilepsy phenotypes in siblings with Norrie disease. Brain Dev 37(10):978–982CrossRefPubMed
23.
go back to reference Staropoli JF, Xin W, Sims KB (2010) Co-segregation of Norrie disease and idiopathic pulmonary hypertension in a family with a microdeletion of the NDP region at Xp11.3-p11.4. J Med Genet 47(11):786–790CrossRefPubMed Staropoli JF, Xin W, Sims KB (2010) Co-segregation of Norrie disease and idiopathic pulmonary hypertension in a family with a microdeletion of the NDP region at Xp11.3-p11.4. J Med Genet 47(11):786–790CrossRefPubMed
24.
go back to reference Whibley A, Urquhart J, Dore J et al (2010) Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements. Eur J Hum Genet 18:1095–1099CrossRefPubMedPubMedCentral Whibley A, Urquhart J, Dore J et al (2010) Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements. Eur J Hum Genet 18:1095–1099CrossRefPubMedPubMedCentral
25.
go back to reference Gu W, Sander T, Heils A et al (2005) A new EF-hand containing gene EFHC2 on Xp11.4: tentative evidence for association with juvenile myoclonic epilepsy. Epilepsy Res 66(1–3):91–98CrossRefPubMed Gu W, Sander T, Heils A et al (2005) A new EF-hand containing gene EFHC2 on Xp11.4: tentative evidence for association with juvenile myoclonic epilepsy. Epilepsy Res 66(1–3):91–98CrossRefPubMed
26.
go back to reference Dreyer B, Brox V, Tranebjaerg L et al (2008) Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II. Hum Mutat 29(3):451CrossRefPubMed Dreyer B, Brox V, Tranebjaerg L et al (2008) Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II. Hum Mutat 29(3):451CrossRefPubMed
27.
28.
go back to reference Marshall JD, Hinman EG, Collin GB et al (2007) Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alström syndrome. Hum Mutat 28(11):1114–1123CrossRefPubMed Marshall JD, Hinman EG, Collin GB et al (2007) Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alström syndrome. Hum Mutat 28(11):1114–1123CrossRefPubMed
29.
Metadata
Title
Clinical and genetic analysis of Indian patients with NDP-related retinopathies
Authors
Dhandayuthapani Sudha
Aparna Ganapathy
Puja Mohan
Ashraf U. Mannan
Shuba Krishna
Srividya Neriyanuri
Meenakshi Swaminathan
Pukhraj Rishi
Subbulakshmi Chidambaram
Jayamuruga Pandian Arunachalam
Publication date
01-06-2018
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 3/2018
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-017-0589-0

Other articles of this Issue 3/2018

International Ophthalmology 3/2018 Go to the issue